
Argenx Reports First Quarter 2025 Financial Results And Provides Business Update
(MENAFN- GlobeNewsWire - Nasdaq) $790 million in first quarter global product net sales First patients treated with VYVGART Hytrulo pre-filled syringe for self-injection in US and Germany CIDP global expansion with positive CHMP opinion for VYVGART-SC ( …